CD40LG and myeloid sarcoma: Additionally interaction between CD40 and CD40L on T cells isolated from MS patients stimulates increased production of IL-12 by APCs57 and IFN-β, used as a therapeutic agent in MS, decreases the level of CD40L on T cells58.